Source: Annual Congress 2006 - Pulmonary arterial hypertension: from bench back to bedside
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. A. Filusch, P. P. Schoene, K. K. Kapadocha, W. R. Rita, H. H. A. Katus, J. F. J. Meyer (Heidelberg, Germany). Low T3-syndrome and respiratory muscle dysfunction in patients with pulmonary arterial hypertension. Eur Respir J 2006; 28: Suppl. 50, 3150

Member's Comments

No comment yet.

Related content which might interest you: Quadriceps dysfunction in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Impairment of respiratory muscle function in pulmonary hypertension Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Comparison of exercise capacity, pulmonary functions, respiratory and peripheral muscle strength between patients with idiopathic pulmonary arterial hypertension and Eisenmenger syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 125-130 Year: 2005 Influence of inspiratory muscle weakness in exercise capacity of patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: International Congress 2016 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2016 Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients Source: Eur Respir J 2004; 24 : 580-586 Year: 2004 Breathing more with weaker respiratory muscles in pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 6-8 Year: 2005 Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension Source: Eur Respir J 2015; 45: 1737-1740 Year: 2015 Apelin improves cardiac output in patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 770 Year: 2009 Inspiratory muscle constraint during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Exercise capacity: from elite athletes to severe impairment Year: 2012 Exercise pathophysiology in patients with pulmonary arterial hypertension Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease Year: 2007 Hyperventilation, reduced muscle strength and pulmonary hypertension are the main determinants of chronic dyspnea in chronic heart failure patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008 Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Assessment of platelet dysfunction in patients with pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020